Daniel W. Chan
Impact in
- Spectroscopy top 0.2%
- Advanced Proteomics Techniques and Applications
- Mass Spectrometry Techniques and Applications
- Cancer Research top 1%
Papers in
-
- Glycosylation and Glycoproteins Research 16
- Advanced Biosensing Techniques and Applications 10
- Molecular Biology Techniques and Applications 7
-
- Prostate Cancer Diagnosis and Treatment 39
- Prostate Cancer Treatment and Research 18
- Co-authors
- Lori J. Sokoll (61 shared papers)Peter B. Luppa (2 shared papers)Danni Li (9 shared papers)Alan W. Partin (31 shared papers)Martin G. Sanda (10 shared papers)Leong L. Ng (1 shared paper)Eric T. Fung (6 shared papers)Hui Zhang (18 shared papers)
- Journals
- The Journal of Urology (25 papers)Clinical Chemistry (10 papers)Urology (9 papers)Clinical Proteomics (8 papers)Clinica Chimica Acta (7 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Daniel W. Chan
158 papers receiving 9.5k citations
Daniel W. Chan's Hit Papers
Peers
Comparison fields: 5 of 157
- Spectroscopy 1.9k
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 2.4k
- Reproductive Medicine 453
- Molecular Biology 3.9k
Countries citing papers authored by Daniel W. Chan
This map shows the geographic impact of Daniel W. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Chan more than expected).
Fields of papers citing papers by Daniel W. Chan
This network shows the impact of papers produced by Daniel W. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Chan. The network helps show where Daniel W. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel W. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer Hit paper breakdown → | 2004 | 779 |
| 2 | Immunosensors—principles and applications to clinical chemistry Hit paper breakdown → | 2001 | 606 |
| 3 | Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group Hit paper breakdown → | 2008 | 596 |
| 4 | 2005 | 449 | |
| 5 | A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range Hit paper breakdown → | 2011 | 369 |
| 6 | Increased plasma DNA integrity in cancer patients. | 2003 | 277 |
| 7 | 1998 | 251 | |
| 8 | Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. | 2002 | 246 |
| 9 | 2004 | 235 | |
| 10 | 2014 | 230 | |
| 11 | 1992 | 225 | |
| 12 | 2010 | 218 | |
| 13 | 2002 | 203 | |
| 14 | 2011 | 196 | |
| 15 | 2006 | 180 | |
| 16 | 2010 | 163 | |
| 17 | HLA-G is a potential tumor marker in malignant ascites. | 2003 | 163 |
| 18 | 2010 | 152 | |
| 19 | 2005 | 152 | |
| 20 | 1987 | 152 |
About Daniel W. Chan
Daniel W. Chan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Spectroscopy, Cancer Research and Oncology, having authored 165 papers that have together received 10.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (39 papers), Advanced Proteomics Techniques and Applications (35 papers), Prostate Cancer Treatment and Research (18 papers), Glycosylation and Glycoproteins Research (16 papers), Mass Spectrometry Techniques and Applications (14 papers), Advanced Biosensing Techniques and Applications (10 papers), Molecular Biology Techniques and Applications (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). The work is most often cited by research in Spectroscopy (1.9k citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (2.4k citations), Reproductive Medicine (453 citations) and Molecular Biology (3.9k citations). Daniel W. Chan has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Lori J. Sokoll, Peter B. Luppa, Danni Li, Alan W. Partin, Martin G. Sanda, Leong L. Ng, Eric T. Fung, Hui Zhang, Zhen Zhang and Zhen Zhang. Their work appears in journals such as The Journal of Urology, Clinical Chemistry, Urology, Clinical Proteomics and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.